Karianne Giller Fleten

8PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 04, 2025
ASO Visual Abstract: Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer.

Yvonne Andersson, Emil Løvstakken, Theodor Malmer Herud

|Aug 11, 2025
Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer.

Yvonne Andersson, Emil Løvstakken, Theodor Malmer Herud

|Dec 19, 2024
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer.

Jeremy B Foote, Tyler E Mattox, Adam B Keeton

|Jul 11, 2023
Intraperitoneal Paclitaxel Is a Safe and Effective Therapeutic Strategy for Treating Mucinous Appendiceal Adenocarcinoma.

Ichiaki Ito, Abdelrahman M G Yousef, Saikat Chowdhury

|Dec 22, 2022
Alginate Microsphere Encapsulation of Drug-Loaded Nanoparticles: A Novel Strategy for Intraperitoneal Drug Delivery.

Karianne Giller Fleten, Astrid Hyldbakk, Caroline Einen

|Oct 29, 2021
Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei.

Kjersti Flatmark, Annette Torgunrud, Karianne G Fleten

Pageof 2

Frequent Collaborators

5 joint publications

Kjersti Flatmark

2 joint publications

Ben Davidson

1 joint publications

Yvonne Andersson

1 joint publications

Annette Torgunrud